Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

INFI
INFINITY PHARMS INC
stock OTC

Inactive
Sep 29, 2023
0.0160USD-4.762%(-0.0008)1,141,812
Pre-market
0.00USD-100.000%(-0.02)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 20, 2022
08:35AM EST  Infinity Pharmaceuticals to Be Featured in a Fireside Chat as Part of B. Riley's 2022 Virtual Oncology Conference   Business Wire
Jan 6, 2022
08:35AM EST  Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Jan 5, 2022
07:22AM EST  Infinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy; Says Expects To End 2022 With $25M-$35M In Cash And Investments   Benzinga
07:13AM EST  Infinity Pharma Expects Net Loss For 2022 To Range $45 Mln To $55 Mln   RTTNews
07:05AM EST  Infinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy and Provides 2022 Guidance   Business Wire
Dec 14, 2021
07:39AM EST  Infinity Pharmaceuticals Added To The NASDAQ Biotechnology Index   Benzinga
07:37AM EST  Infinity Pharma Added To NASDAQ Biotechnology Index   RTTNews
07:35AM EST  Infinity Pharmaceuticals Added to the NASDAQ Biotechnology Index   Business Wire
Dec 13, 2021
08:35AM EST  Infinity Pharmaceuticals to be Featured in B. Riley Fireside Chat   Business Wire
Dec 10, 2021
11:26AM EST  Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial   Benzinga
08:41AM EST  Why Infinity Pharmaceuticals Is Rising In Pre-market?   RTTNews
08:12AM EST  Infinity Pharma : Durable Clinical Benefit Seen With Eganelisib Combination In Breast Cancer Trial; Stock Up   RTTNews
07:59AM EST  Infinity Pharma Offers Updated Data From Phase 2 MARIO-3 Trial Presented At San Antonio Breast Cancer Symposium: '88.6% of Evaluable 1L TNBC Patients Achieved Tumor Reduction'   Benzinga
07:58AM EST  Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 San Antonio Breast Cancer Symposium   Business Wire
Dec 7, 2021
08:26AM EST  The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Dar   Benzinga
Dec 6, 2021
08:35AM EST  Infinity Pharmaceuticals to Host an Investor Event on Updated MARIO-3 Data Presented at the 2021 San Antonio Breast Cancer Symposium   Business Wire
06:07AM EST  The Week Ahead In Biotech (Dec. 6-Dec. 11): Dar FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More   Benzinga
Nov 2, 2021
05:59PM EDT  Infinity Pharmaceuticals Q3 EPS $(0.12) Beats $(0.13) Estimate   Benzinga
11:52AM EDT  Infinity Pharmaceuticals's Return On Capital Employed Insights   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
Oct 18, 2021
10:22AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2021   Benzinga
06:28AM EDT  HC Wainwright & Co. Initiates Coverage On Infinity Pharmaceuticals with Buy Rating, Announces Price Target of $9   Benzinga
Sep 7, 2021
08:16AM EDT  Biopharmaceutical company Infinity Pharmaceuticals, Inc. (INFI) announced Tuesday the appointment of Robert Ilaria, Jr. as Chief Medical Officer. In addition, Brian Schwartz will be transitioning from his role as Consulting Chief Physician to the Infinity Board of Directors.   RTTNews
07:52AM EDT  Infinity Pharma Appoints Robert Ilaria As Chief Medical Officer And Brian Schwartz To Board   RTTNews
Aug 2, 2021
02:50PM EDT  Mid-Afternoon Market Update: Nasdaq Gains 50 Points; Marin Software Shares Plummet   Benzinga
12:07PM EDT  Mid-Day Market Update: Crude Oil Down 2.5%; Exicure Shares Spike Higher   Benzinga
10:23AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2021   Benzinga
05:44AM EDT  JP Morgan Upgrades Infinity Pharmaceuticals to Overweight, Announces $6 Price Target   Benzinga
Jul 28, 2021
03:32PM EDT  Infinity Pharmaceuticals Shares See Volume, Co. Granted European Patent Specification For 'HETEROCYCLIC COMPOUNDS AND USES THEREOF'   Benzinga
10:23AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2021   Benzinga
07:45AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
05:38AM EDT  Wells Fargo Upgrades Infinity Pharmaceuticals to Overweight, Raises Price Target to $14   Benzinga
Jul 27, 2021
11:13AM EDT  Infinity Pharma Stock Drops After Updated Data From Bladder & Breast Cancer Trials, Q2 Earnings   Benzinga
11:13AM EDT  The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts   Benzinga
11:13AM EDT  Infinity Pharmaceuticals Highlights Presentation Of Updated Data From Phase 2 MARIO-275 Trial In Urothelial Cancer And Phase 2 MARIO-3 Trial In Triple Negative Breast Cancer   Benzinga
Jul 25, 2021
10:05AM EDT  The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More   Benzinga
Jul 20, 2021
08:36AM EDT  Infinity Pharmaceuticals Hosting Webinar On MARIO-3 And MARIO-275 Phase 2 Trials   Benzinga
May 13, 2021
04:53PM EDT  Infinity Pharma S-3 Shows Registration For $250M Mixed Securities Shelf Offering   Benzinga
04:40PM EDT  Infinity Pharmaceuticals: Q1 Earnings Insights   Benzinga
04:27PM EDT  Infinity Pharmaceuticals Q1 EPS $(0.15) Misses $(0.12) Estimate   Benzinga
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
Mar 18, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 18, 2021   Benzinga
08:11AM EDT  Truist Securities Initiates Coverage On Infinity Pharmaceuticals with Buy Rating, Announces Price Target of $12   Benzinga
Mar 17, 2021
08:26AM EDT  Wells Fargo Maintains Equal-Weight on Infinity Pharmaceuticals, Raises Price Target to $4   Benzinga
Mar 16, 2021
04:35PM EDT  Infinity Pharmaceuticals: Q4 Earnings Insights   Benzinga
04:16PM EDT  Infinity Pharmaceuticals Reports FY20 EPS $(0.68) Up From $(0.83) YoY, Sales $1.72M Down From $3.05M YoY   Benzinga
04:05PM EDT  Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development   Business Wire
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
04:46AM EDT  Earnings Scheduled For March 16, 2021   Benzinga
Mar 14, 2021
08:14AM EDT  Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations   Benzinga
Feb 18, 2021
10:02AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021   Benzinga
06:05AM EST  Piper Sandler Initiates Coverage On Infinity Pharmaceuticals with Overweight Rating, Announces Price Target of $7   Benzinga
Feb 12, 2021
08:38AM EST  Infinity Pharmaceuticals Announces Pricing Of $80M Public Offering Of 21M Shares Priced At $3.80/Share   Benzinga
Feb 11, 2021
04:02PM EST  Infinity Announces A Common Stock Offering; No Terms Disclosed   Benzinga
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 6, 2021
12:42PM EST  The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight   Benzinga
Feb 5, 2021
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 5, 2021   Benzinga
06:48AM EST  JP Morgan Upgrades Infinity Pharmaceuticals to Neutral   Benzinga
Jan 25, 2021
08:45AM EST  Immunotherapy Using Immune-Checkpoint Inhibitors (ICI) Modulators Are   PR Newswire
Jan 21, 2021
08:24AM EST  Benzinga Pro's Top 5 Stocks To Watch For Thursday, Jan. 21, 2021: AMD, INFI, BATT, FSRV, FTOC   Benzinga
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 11, 2021
08:20AM EST  Infinity Pharmaceuticals To Present MARIO-275 Phase 2 Data In Patients Qith Advanced Urothelial Cancer At ASCO Genitourinary Cancers Symposium Feb. 11-13   Benzinga
Jan 6, 2021
09:12AM EST  Infinity Pharma Reports Ended 2020 With ~$34.1M In Cash, Investments   Benzinga
09:12AM EST  Infinity Pharma Offers Data On MARIO-275 For Patients With Metastatic Urothelial Cancer, On MARIO-3   Benzinga
Dec 10, 2020
07:42AM EST  The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations   Benzinga
Dec 9, 2020
12:25PM EST  Why Sorrento And Infinity Are Moving Today   Benzinga
10:23AM EST  Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Tops Views   Benzinga
09:11AM EST  Infinity Pharma Reports Presentation Of Front-Line Triple Negative Breast Cancer Data From Ongoing Phase 2 MARIO-3 Trial At San Antonio Breast Cancer Symposium: '100% of Evaluable Patients Achieved Tumor Reduction Irrespective of PD-L1 Status'   Benzinga
Dec 6, 2020
08:41AM EST  Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace   Benzinga
Dec 4, 2020
08:04AM EST  The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs   Benzinga
Nov 20, 2020
08:06AM EST  The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 17, 2020
08:32AM EST  The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration   Benzinga
Nov 16, 2020
10:02AM EST  68 Stocks Trading Near 52-Week Highs Just After Open On Monday, Nov. 16, 2020:   Benzinga
Nov 9, 2020
05:15PM EST  Recap: Infinity Pharmaceuticals Q3 Earnings   Benzinga
04:23PM EST  Infinity Pharmaceuticals Q3 EPS $(0.16), Inline, Sales $496.00K Beat $160.00K Estimate   Benzinga
08:08AM EST  Infinity Pharma Reports Presentation Of New MARIO-1 Phase 1/1b Data At Society For Immunotherapy Of Cancer Meeting   Benzinga
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Sep 29, 2020
07:36AM EDT  Infinity Receives Fast Track Designation For Eganelisib In Combination With A Checkpoint Inhibitor And Chemotherapy For First-Line Treatment Of Advanced TNBC   Benzinga
Jul 30, 2020
04:25PM EDT  Infinity Pharmaceuticals Q2 EPS $(0.16) Beats $(0.19) Estimate, Sales $360.00K Beat $160.00K Estimate   Benzinga
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 23, 2020
07:35AM EDT  Infinity Announces the Date of Its Second Quarter Financial Results Conference Call and Webcast   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC